The Therapeutic Effects of QihaPingchuan Capsule in Combination with Triple Therapy (ICS+LABA+LAMA) on Chronic Obstructive Pulmonary Disease
1, 1, 1, 1, 1, 1, 1
- 1Department of Respiratory (Lung Disease), Xianghe County Hospital of Integrated Chinese and Western Medicine, Langfang, CHINA.
CORRESPONDENCE
Dr. Weidong Zhao,
Department of Respiratory (Lung Disease), Xianghe County Hospital of Integrated Chinese and Western Medicine, No. 8, Ping’an Street, Anping Development Zone, Xianghe County, Langfang, Hebei-065400, CHINA.
Received: 21-03-2024; Accepted: 06-06-2024.
Volume 58, Issue 4 · pp. 1077-1083 · 2024 · DOI: 10.5530/ijper.58.4.119
ABSTRACT
Objectives: To explore the curative effect of QihaPingchuan Capsule combined with triple therapy [Inhaled Corticosteroid (ICS)+Long-Acting β2 receptor Agonist (LABA)+Long-Acting Anticholinergic drug (LAMA)] on Chronic Obstructive Pulmonary Disease (COPD).Materials and Methods: A total of 92 patients with COPD admitted to the hospital were enrolled between January 2021 and October 2022. According to the random number table method, they were divided into Group A and Group B, with 46 cases in each group. Group B was given routine symptomatic treatment and triple therapy, while Group A was additionally treated with Qiha Pingchuan Capsules. All were treated for two weeks. The clinical curative effect, scores of TCM syndromes and COPD Assessment Test (CAT), 6-Minute Walk Distance (6MWD), Forced Vital Capacity (FVC), Forced Expiratory Volume in one second (FEV1), Peak Expiratory Flow (PEF), Partial Pressure of Oxygen (PO2), partial Pressure of Carbon dioxide (PCO2), serum C-Reactive Protein (CRP), Interleukin-8 (IL-8) and incidence of adverse reactions were compared between the two groups before and after treatment.Results: The total response rate of treatment in group A was significantly higher than in group B (89.13% vs. 71.74%, p0.05).Conclusion: QihaPingchuan Capsule combined with triple therapy (ICS+LABA+LAMA) can improve the clinical curative effect, effectively relieve clinical symptoms and improve pulmonary function and inflammatory response in COPD patients, with reasonable safety.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Dong, Z., Dong, S., Li, J., Zhu, Y., Ma, Z., Hou, Y., & Zhao, W. (2024). The Therapeutic Effects of QihaPingchuan Capsule in Combination with Triple Therapy (ICS+LABA+LAMA) on Chronic Obstructive Pulmonary Disease. Indian Journal of Pharmaceutical Education and Research, 58(4), 1077-1083. https://doi.org/10.5530/ijper.58.4.119
Copyright and licence
© 2024 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited. CC BY 4.0